The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC related information was provided by the message!
  • No CSPEC computer assertion could be determined for this classification!

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_000138.5(FBN1):c.6866G>C (p.Cys2289Ser)

CA392331872

632813 (ClinVar)

Gene: FBN1 (HGNC:2200)
Condition: Marfan syndrome (MONDO:0007947)
Inheritance Mode: Autosomal dominant inheritance
UUID: 3b16a9ab-115c-4598-9c85-22f4ebe5eb1c
Approved on: 2024-08-22
Published on: 2024-08-22

HGVS expressions

NM_000138.5(FBN1):c.6866G>C (p.Cys2289Ser)
NM_000138.5:c.6866G>C
NC_000015.10:g.48430676C>G
CM000677.2:g.48430676C>G
NC_000015.9:g.48722873C>G
CM000677.1:g.48722873C>G
NC_000015.8:g.46510165C>G
NG_008805.2:g.220113G>C
ENST00000559133.6:c.6866G>C
ENST00000674301.2:c.*317G>C
ENST00000682170.1:n.475G>C
ENST00000316623.10:c.6866G>C
ENST00000674301.1:c.1970G>C
ENST00000316623.9:c.6866G>C
ENST00000559133.5:c.2173G>C
ENST00000560720.1:n.153G>C
NM_000138.4:c.6866G>C
More

Likely Pathogenic

Met criteria codes 4
PM2_Supporting PP3 PP2 PM1_Strong
Not Met criteria codes 1
BS2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
FBN1 VCEP
NM_00138 c.6866G>C is a missense variant in FBN1 predicted to cause a substitution of cysteine by serine at amino acid 2289 (p.Cys2289Ser). This variant is not reported in the literature in any individuals with Marfan syndrome (MFS). This variant has been reported once in ClinVar as Likely pathogenic and once as uncertain significance (Variation ID: 632813). This variant is not present in gnomAD (PM2_Sup; https://gnomad.broadinstitute.org/ v4.0.0). This variant affects a cysteine residue in a calcium binding EGF domain. Cysteine residues are believed to be involved in the formation of disulfide bridges which are essential for the protein structure (PM1_strong). The constraint z-score for missense variants affecting FBN1 is 8.18 (PP2; https://gnomad.broadinstitute.org/ v4.0.0). Computational prediction tools and conservation analysis suggest that this variant may impact the protein (REVEL: 0.992, PP3). In summary, this variant meets criteria to be classified as likely pathogenic for Marfan syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen FBN1 VCEP: PM1_Strong, PM2_Sup,PP3, PP2.
Met criteria codes
PM2_Supporting
Absent in gnomAD
PP3
REVEL score: 0.992
PP2
Missense variant
PM1_Strong
Disrupts a Cysteine residue in cbEGF35
Not Met criteria codes
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.